(Q46003457)

18 December 2017

title

Cost-effective management of heart failure. (English)

1 reference

18 December 2017

0 references

Parmley WW

1

1 reference

18 December 2017

publication date

1 March 1996

1 reference

18 December 2017

published in

Clinical Cardiology

1 reference

18 December 2017

volume

19

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

240-242

1 reference

18 December 2017

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

The treatment of congestive heart failure. Digitalis glycosides are still the primary mode of therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190319

7 January 2021

Identifiers

DOI

10.1002/CLC.4960190319

1 reference

18 December 2017

1 reference

18 December 2017